Berman Steven M, Ozkaragoz Tulin, Noble Ernest P, Antolin Tim, Sheen Courtney, Siddarth Prabha, Conner Bradley T, Ritchie Terry
Alcohol Research Center, Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90024, USA.
Alcohol. 2003 Jul;30(3):201-10. doi: 10.1016/j.alcohol.2003.06.002.
Children of alcoholics have increased risk for substance abuse problems. Self-medication of negative affect may be one developmental path to future substance abuse. Because the 146 young (adolescent) children of alcoholics in the current sample had not used enough abused substances to study substance use directly, the relation of substance abuse risk markers to negative affect was assessed. Because the D2 dopamine receptor (DRD2) A1 allele has been associated with alcoholism and other substance use disorders, negative affect, measured by the Beck Depression Inventory (BDI), was determined in four groups of children: boys and girls with the A1+ allele (A1A1 and A1A2 genotypes) and with the A1- allele (A2A2 genotype). The other risk markers were stress, low amplitude of the P300 evoked potential, poor visuospatial functioning, novelty seeking (NS), and harm avoidance (HA). Stress was correlated with BDI scores in all groups. In contrast, low P300 was associated with BDI scores only in boys with the A1+ allele (P = .04), NS was associated with BDI scores only in girls with the A1+ allele (P = .02), and HA was associated with BDI scores only in boys with the A1- allele (P = .01). In addition, boys with the A1+ allele had lower BDI (P = .05) and HA (P = .005) scores than the respective scores for boys with the A1- allele. Girls with the A1- allele had lower HA scores compared with scores for boys with the A1- allele (P = .02). Girls with the A1+ allele had lower visuospatial functioning than that of boys with the A1+ allele (P<.001). Results indicate that both sex and DRD2 genotype modify associations between negative affect and other substance abuse risk markers.
酗酒者的子女出现药物滥用问题的风险更高。自我用药来缓解负面影响可能是未来药物滥用的一条发展路径。由于当前样本中的146名酗酒者的年幼(青少年)子女尚未使用足够多的滥用药物来直接研究药物使用情况,因此评估了药物滥用风险标志物与负面影响之间的关系。因为D2多巴胺受体(DRD2)A1等位基因与酗酒及其他药物使用障碍有关,所以通过贝克抑郁量表(BDI)来测量负面影响,该量表对四组儿童进行了测定:携带A1+等位基因(A1A1和A1A2基因型)和携带A1-等位基因(A2A2基因型)的男孩和女孩。其他风险标志物包括压力、P300诱发电位的低波幅、视觉空间功能差、寻求新奇(NS)和避免伤害(HA)。压力与所有组的BDI得分相关。相比之下,低P300仅与携带A1+等位基因的男孩的BDI得分相关(P = 0.04),NS仅与携带A1+等位基因的女孩的BDI得分相关(P = 0.02),而HA仅与携带A1-等位基因的男孩的BDI得分相关(P = 0.01)。此外,携带A1+等位基因的男孩的BDI得分(P = 0.05)和HA得分(P = 0.005)低于携带A1-等位基因的男孩的相应得分。携带A1-等位基因的女孩的HA得分低于携带A1-等位基因的男孩(P = 0.02)。携带A1+等位基因的女孩的视觉空间功能低于携带A1+等位基因的男孩(P<0.001))。结果表明,性别和DRD2基因型都会改变负面影响与其他药物滥用风险标志物之间的关联。